Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polymorphism of IL-1 receptor antagonist gene: role in cancer.
Sehouli J, Mustea A, Könsgen D, Katsares I, Lichtenegger W. Sehouli J, et al. Among authors: konsgen d. Anticancer Res. 2002 Nov-Dec;22(6A):3421-4. Anticancer Res. 2002. PMID: 12530098 Review.
Expression of IL-10 in patients with ovarian carcinoma.
Mustea A, Könsgen D, Braicu EI, Pirvulescu C, Sun P, Sofroni D, Lichtenegger W, Sehouli J. Mustea A, et al. Among authors: konsgen d. Anticancer Res. 2006 Mar-Apr;26(2C):1715-8. Anticancer Res. 2006. PMID: 16617566
Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R. Hefler LA, et al. Among authors: konsgen d. Clin Cancer Res. 2007 Feb 1;13(3):898-901. doi: 10.1158/1078-0432.CCR-06-1008. Clin Cancer Res. 2007. PMID: 17289883 Free article.
Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis.
Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Noske A, Weichert W, Buckendahl AC, Budczies J, Müller BM, Elwali NE, Dietel M, Denkert C. Faggad A, et al. Among authors: konsgen d. Histopathology. 2009 May;54(6):657-66. doi: 10.1111/j.1365-2559.2009.03297.x. Histopathology. 2009. PMID: 19438741
Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis.
Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Weichert W, Noske A, Budczies J, Müller BM, Buckendahl AC, Röske A, Eldin Elwali N, Dietel M, Denkert C. Faggad A, et al. Among authors: konsgen d. Mod Pathol. 2009 Apr;22(4):579-88. doi: 10.1038/modpathol.2009.14. Epub 2009 Mar 6. Mod Pathol. 2009. PMID: 19270648 Free article.
Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.
Ioana Braicu E, Mustea A, Toliat MR, Pirvulescu C, Könsgen D, Sun P, Nürnberg P, Lichtenegger W, Sehouli J. Ioana Braicu E, et al. Among authors: konsgen d. Gynecol Oncol. 2007 Mar;104(3):680-5. doi: 10.1016/j.ygyno.2006.10.014. Epub 2006 Dec 1. Gynecol Oncol. 2007. PMID: 17141301
Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.
Sehouli J, Akdogan Z, Heinze T, Könsgen D, Stengel D, Mustea A, Lichtenegger W. Sehouli J, et al. Among authors: konsgen d. Anticancer Res. 2003 Mar-Apr;23(2A):1115-8. Anticancer Res. 2003. PMID: 12820357
Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.
Mustea A, Sehouli J, Könsgen D, Stengel D, Sofroni D, Lichtenegger W. Mustea A, et al. Among authors: konsgen d. Anticancer Res. 2003 Mar-Apr;23(2A):1099-102. Anticancer Res. 2003. PMID: 12820354
24 results
Jump to page
Feedback